CU6 - ASX Charts, page-263

The interesting thing is that when it was at 40c there was no indication that the company was in anyway sick. It was a very easy investment decision at the time.
the company’s market cap dropped to below their cash on hand and all the results were proving that the tech was working as documented in the company annual reports. It was also clear from their announcements that there is an addressable market that was generating huge revenues for our competitors. From the early results our products appeared to be superior so naturally there was confidence that we could attain best in class eventually.
money and cash burn was never an issue due to the big IPO.
the only question was if the ongoing results would continue to show we could be better at treating and diagnosing patients. So far it has indicated that.
many posters here have been on the ride since 40c although most also took part in the IPO and pre IPO so have averages in the 60’s. None that I speak to are selling yet.
bring on results and a massive sale to BP.